Evidence map›Paper›PMID 33050076›Full record

ArticleMolecules (Basel, Switzerland)2020

Aromadendrin Inhibits T Cell Activation via Regulation of Calcium Influx and NFAT Activity.

Hyun-Su Lee, Gil-Saeng Jeong

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Synergistic roles of NFATc1 and c-Jun in immunomodulation.Biochemistry and biophysics reports · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Gene editing of authenticHorticulture research · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Identification of Flavonoids in the Leaves ofPlants (Basel, Switzerland) · 2021
    Article
  10. Gm40600 promotes CD4Immunology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hyun-Su LeeCollege of Pharmacy, Keimyung University, 1095 Dalgubeol-daero, Daegu 42601, Korea.
Gil-Saeng JeongCollege of Pharmacy, Keimyung University, 1095 Dalgubeol-daero, Daegu 42601, Korea.
Keimyung University · KR

Funding

National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2016R1A6A1A03011325
6 · The paper itself

Abstract

The objective of this study was to assess the inhibitory effect of the flavonoid aromadendrin on T cell activity to identify a non-cytotoxic immunosuppressive reagent. Conventional and qualitative PCR, MTT assays, flow cytometry and Western blotting were used to evaluate the effect of aromadendrin on the activity, cell viability and confluency, and proximal signal transduction of activated T cells. Aromadendrin effectively regulated IL-2 and IFNγ production in vitro from activated Jurkat T cells without cytotoxicity. Pre-treatment with aromadendrin also suppressed the expression levels of surface molecules CD69, CD25, and CD40L. Reduced calcium (Ca

Indexed as

Antigens, CDAntigens, Differentiation, T-LymphocyteCalciumCD40 LigandCD69 AntigensCell Line, TumorCell NucleusCell SurvivalFlavonoidsHumansImmunosuppressive AgentsInterleukin-2Interleukin-2 Receptor alpha SubunitJurkat CellsLectins, C-TypeLymphocyte ActivationAntigens, CDAntigens, Differentiation, T-LymphocytearomadedrinCalciumCD40 LigandCD69 AntigensFlavonoidsImmunosuppressive AgentsInterleukin-2Interleukin-2 Receptor alpha SubunitLectins, C-TypeMitogen-Activated Protein KinasesNFATC Transcription FactorsNF-kappa BcalciumIL-2MAPKNFATT cells

Identifiers

PMID33050076
PMCPMC7582607
OpenAlexW3092596012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.